EPCAM and breast carcinoma: Clinical studies have shown that EpCAM is highly expressed in various cancers, including breast cancer, pancreatic cancer [17], various epithelial cancers, and OSCC, and its overexpression is associated with poor prognosis [18,19,20,21,22,23].